相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。TR-FRET-Based High-Throughput Screening Assay for Identification of UBC13 Inhibitors
Charitha Madiraju et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
E2s: structurally economical and functionally replete
Dawn M. Wenzel et al.
BIOCHEMICAL JOURNAL (2011)
Ubiquitin in Motion: Structural Studies of the Ubiquitin-Conjugating Enzyme∼Ubiquitin Conjugate
Jonathan N. Pruneda et al.
BIOCHEMISTRY (2011)
Expanding role of ubiquitination in NF-kappa B signaling
Siqi Liu et al.
CELL RESEARCH (2011)
Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma
Daruka Mahadevan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Oncogenically active MYD88 mutations in human lymphoma
Vu N. Ngo et al.
NATURE (2011)
Analysis of the coding genome of diffuse large B-cell lymphoma
Laura Pasqualucci et al.
NATURE GENETICS (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
The predator becomes the prey: regulating the ubiquitin system by ubiquitylation and degradation
Allan M. Weissman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Chemical Biology Strategy Reveals Pathway-Selective Inhibitor of NF-κB Activation Induced by Protein Kinase C
Ranxin Shi et al.
ACS CHEMICAL BIOLOGY (2010)
The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma
G. Wei Xu et al.
BLOOD (2010)
Targeted treatment and new agents in diffuse large B cell lymphoma
Sophie Dupire et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
B cells as therapeutic targets in SLE
Inaki Sanz et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Mechanisms of Disease: Aggressive Lymphomas.
Georg Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation
Johanna Scheper et al.
PLOS ONE (2010)
Signaling to NF-κB: Regulation by Ubiquitination
Ingrid E. Wertz et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Oncogenic Activation of NF-kappa B
Louis M. Staudt
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
p53 Research: The Past Thirty Years and the Next Thirty Years
David Lane et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Antigen Receptor Signaling to NF-κB via CARMA1, BCL10, and MALT1
Margot Thome et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Keiichiro Honma et al.
BLOOD (2009)
Regulatory ubiquitylation in response to DNA double-strand breaks
Stephanie Panier et al.
DNA REPAIR (2009)
Direct activation of protein kinases by unanchored polyubiquitin chains
Zong-Ping Xia et al.
NATURE (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Building ubiquitin chains: E2 enzymes at work
Yihong Ye et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Regulation of hematopoiesis by the K63-specific ubiquitin-conjugating enzyme Ubc13
Xuefeng Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
NF-κB as a Critical Link Between Inflammation and Cancer
Michael Karin
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
Leucettamol A: A new inhibitor of Ubc13-Uev1A interaction isolated from a marine sponge, Leucetta aff. microrhaphis
Sachiko Tsukamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Diffuse Large B-Cell Lymphoma
Jonathan W. Friedberg et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2008)
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma
Georg Lenz et al.
SCIENCE (2008)
Protein kinase C-associated kinase is required for NF-κB signaling and survival in diffuse large B-cell lymphoma cells
Sang-Woo Kim et al.
BLOOD (2008)
Transcriptional activation of histone genes requires NPAT-Dependent recruitment of TRRAP-Tip60 complex to histone promoters during the G(1)/S phase transition
Michael DeRan et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics
Yili Yang et al.
CANCER RESEARCH (2007)
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation
Betty Lamothe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cutting edge: Pivotal function of Ubc13 in thymocyte TCR signaling
Masahiro Yamamoto et al.
JOURNAL OF IMMUNOLOGY (2006)
Regulation of p53 localization and activity by Ubc13
Aaron Laine et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling
Masahiro Yamamoto et al.
NATURE IMMUNOLOGY (2006)
Transcription factor NF-κB differentially regulates death receptor 5 expression involving histone deacetylase 1
S Shetty et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Control of lymphocyte development by nuclear factor-κB
U Siebenlist et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Constitutive nuclear factor κB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells
RE Davis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)